Related Experiment Video
Updated: Apr 29, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
A systematic approach incorporating family history improves identification of cardiovascular disease risk
Mariam Kashani1, Arn Eliasson, Marina Vernalis
1Mariam Kashani, DNP, CRNP School of Nursing, Johns Hopkins University, Baltimore, and Chief Scientific Director, Integrative Cardiac Health Project, Walter Reed National Military Medical Center, Bethesda, Maryland. Arn Eliasson, MD Senior Physician Research Consultant, Integrative Cardiac Health Project, Walter Reed National Military Medical Center, Bethesda, Maryland. Marina Vernalis, DO Executive Medical Director, Integrative Cardiac Health Project, Walter Reed National Military Medical Center, Bethesda, Maryland. Karla Bailey, MS Data Outcomes Analyst, Integrative Cardiac Health Project, Walter Reed National Military Medical Center, Bethesda, Maryland. Mary Terhaar, DNSc Director, Doctor of Nursing Practice Program, School of Nursing, Johns Hopkins University, Baltimore, Maryland.
Insights
Incorporating family history (FH) into cardiovascular disease (CVD) risk assessment identifies more high-risk patients. This systematic approach improves CVD risk stratification and targets prevention more effectively.
Area of Science:
- Cardiology
- Preventive Medicine
- Clinical Risk Assessment
Background:
- Family history (FH) is a key cardiovascular disease (CVD) predictor, yet not integrated into standard risk scores.
- Current risk assessment may underestimate patient risk, leaving them vulnerable to CVD.
- Nurses collect FH but lack tools to utilize it in risk estimation.
Purpose of the Study:
- To evaluate a systematic method for incorporating FH into CVD risk assessment.
- To validate risk reclassification using carotid intima-media thickness (CIMT) as a measure of atherosclerosis.
Main Methods:
- A systematic FH assessment was applied to 239 patients with low/intermediate risk by Framingham Risk Score.
- Positive FH for premature CVD (defined by age of event in first-degree relatives) led to risk reclassification.
- Reclassification accuracy was validated with CIMT measurements.
Main Results:
- 100% adherence to the systematic FH assessment protocol was observed.
- 48% of patients (115/239) were reclassified to high risk due to positive FH.
- Reclassified patients showed significantly higher rates of subclinical atherosclerosis (75% vs. 55% by CIMT, P < 0.001).
- Positive FH was the strongest predictor of abnormal CIMT (OR 2.6, P=0.001).
Conclusions:
- The systematic approach effectively enhances CVD risk assessment by identifying previously unrecognized high-risk individuals.
- This method reduces practice variability and allows for more targeted preventive strategies.
- Incorporating FH improves risk stratification for better CVD prevention outcomes.
Background:
Although family history (FH) is an independent predictor of cardiovascular disease (CVD) risk, traditional risk scores do not incorporate FH. Nurse practitioners routinely solicit FH but have no mechanism to incorporate the information into risk estimation. Underestimation of risk leaves clinicians misinformed and patients vulnerable to the CVD epidemic.
Objective:
We examined a systematic approach incorporating FH in CVD risk assessment, validating risk reclassification using carotid intima-media thickness (CIMT), a surrogate measure of atherosclerosis.
Methods:
Of 413 consecutive patients prospectively enrolled in the Integrative Cardiac Health Project Registry, a subgroup of 239 was low or intermediate risk by the Framingham Risk Score. A systematic approach for the assessment of FH was applied to this subgroup of the registry. A positive FH for premature CVD, defined as a first-degree relative having a CVD event before the age of 55 years in men and 65 years in women, conferred reclassification to high risk. Reclassification was validated with CIMT results.
Results:
Chart audits revealed adherence to the systematic approach for FH assessment in 100% of cases. This systematic approach identified 115 of 239 (48%) patients as high risk because of positive FH. Of the reclassified patients, 75% had evidence of subclinical atherosclerosis by CIMT versus 55% in the patients not reclassified, P < 0.001. Logistic regression identified positive FH for premature CVD (odds ratio, 2.6; P = 0.001) among all variables, as the most significant predictor of abnormal CIMT, thus increasing risk for CVD.
Conclusions:
The Integrative Cardiac Health Project systematic approach incorporating FH into risk stratification enhances CVD risk assessment by identifying previously unrecognized high-risk patients, reduces variability in practice, and appropriately targets more stringent therapeutic goals for prevention.
More Related Videos
08:21Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
Published on: July 21, 2023
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Related Concept Videos
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Coronary Artery Disease I: Introduction
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis III: Management
Assessment of the Cardiovascular System II: Inspection
Head and Neck
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT